Lantern Pharma (LTRN) Tops Q3 EPS by 19c

Lantern Pharma (NASDAQ: LTRN) reported Q3 EPS of ($0.29), $0.19 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target